biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Pathetic!!

<< Previous

Bullboard Posts

Next >>

Comment by zwerp2000on Feb 28, 2021 2:50pm

131 Views

Post# 32682031

RE:RE:RE:Pathetic!!

Well what a surprise. The mentally unstable craighenry is attacking another poster. And as for your boy JD that you have a hard on for, who cares what he has to say? He's been here for years and what has he predicted that came true? Nothing! Some posters like to read his posts because they are bullish so it makes them feel better about their investment here but when you take a step back, you'll see that he's been spewing this garbage for years. Are ready to blow another gasket again, pretty boy?

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand